76.病人因軟組織肉瘤(soft tissue sarcoma)接受doxorubicin 25 mg/m2/day IV D1-D3、ifosfamide 2000 mg/m2/day IV D1-D3治療;醫師同時處方mesna。有關mesna的劑量與用途,下列何者正確?
(A)12 mg/m2/day,以預防doxorubicin之心臟毒性
(B)1200 mg/m2/day,以預防ifosfamide之出血性膀胱炎
(C)1200 mg/m2/day,以預防ifosfamide之中樞神經毒性
(D)250 mg/m2/day,以預防doxorubicin之肝毒性
答案:登入後查看
統計: A(190), B(2748), C(73), D(19), E(0) #2972430
統計: A(190), B(2748), C(73), D(19), E(0) #2972430
詳解 (共 6 筆)
#6520294
| Chemotherapy | Toxic Metabolite | Effect | Mesna’s Role |
|---|---|---|---|
| Cyclophosphamide / Ifosfamide | Acrolein | Hemorrhagic cystitis | Binds and inactivates acrolein in the bladder |
2
0